ArticleNature genetics2014
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations.
Shinji Kohsaka et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
106 papers cite itlatest 60 shown
this papertrialcites it